logo
NHS ‘to rely on migrants' as Government cuts British nurse training

NHS ‘to rely on migrants' as Government cuts British nurse training

Yahoo5 hours ago

The Government has cut funding for nursing courses in a move that risks undermining its pledge to end the NHS's reliance on foreign workers.
Ministers have quietly frozen grants that are paid to universities to help them cover the higher costs of training medical workers.
Critics reacted by warning that the move, which represents a real-terms cut, would 'worsen an already difficult situation' in the sector and 'leave us more reliant' on imported labour.
It will also prompt fears of further cuts down the line, with education set to be one of the losers in Rachel Reeves's spending review this week.
Universities are already struggling to keep nursing courses afloat, with research showing that many are cutting lecturer jobs to save cash.
In last year's manifesto, Labour pledged to 'end the long-term reliance on overseas workers' with a 'workforce and training plan' for the NHS.
However, Bridget Phillipson, the Education Secretary, has now frozen grants which are paid to universities to cover the extra costs of running medical courses.
Those include courses for nursing, midwifery and 'allied health professionals' such as paramedics, radiographers and occupational therapists.
In a letter to the Office for Students, she said the per-student funding levels should be kept the same as last year, representing a real-terms cut.
That is part of an overall reduction of £108 million in the cash that has been made available for the Strategic Priorities Grant this year.
Patricia Marquis, the executive director for the Royal College of Nursing in England, said nursing courses were already under threat from the 'financial crisis' at universities.
'A freeze in per student funding, effectively a real-terms cut, could make a bad situation worse, resulting in not only more job losses, but impacting the very financial viability of nursing courses,' she warned.
'University courses are the single biggest route into the profession, and this would be a disaster. Additional funding should be released to protect nursing courses in response to rising costs.'
Vivienne Stern, the chief executive of Universities UK, also warned that the cuts to the grant risked 'worsening an already difficult situation'.
She said that the move, combined with a recent decision to slash cash for apprenticeships, would have a 'detrimental impact on training our healthcare workforce'.
'Universities are committed to delivering what this country needs, including a strong and sustainable NHS workforce, and are crucial to training talent,' she said.
'We can't create a future-proof NHS workforce without long-term, sustained investment from the government.'
Ms Phillipson said in her letter to the OfS that universities should prioritise funding for nursing courses as 'a strategically important subject'.
She targeted grants for other courses and in particular media studies and journalism, which have been derided by some as 'Mickey Mouse' degrees.
But despite that, it appears there was still only enough money in the pot for her to restrict the hit to medical courses to a real-terms cut.
Laura Trott, the shadow education secretary, said the move was 'yet more evidence that Labour aren't serious about cutting immigration'.
'At a time when we should be training more British people to become nurses, they've cut teaching grants for universities and scrapped almost all higher-level apprenticeships, leaving an 11,000 shortfall in the NHS workforce plan,' she said.
'These decisions will leave us more reliant on foreign labour, when we should be training British people for British jobs.'
The Department for Education is facing steep real-terms cuts to its budget when the Chancellor unveils her spending review on Wednesday. She will set out the annual funding totals that all Whitehall departments receive from next year until almost the end of the decade.
Most are expecting to see their budgets squeezed to free up more cash for health and defence, which will be the two big winners.
Within education, the schools budget is ring-fenced, meaning it cannot be cut.
Early years provision, meanwhile, is a flagship Labour policy with the party pledging to fund the creation of 100,000 new nursery places.
That means that higher education, including universities and apprenticeships, is expected to bear the brunt of the cuts imposed on the department.
A Government spokesman said: 'We hugely value the work of talented nurses and midwives which is why we have prioritised Strategic Priorities Grant funding for important, high-cost courses, including nursing and midwifery, that are vital for economic growth and our Plan for Change.
'The dire situation we inherited has meant this Government must take tough decisions to put universities on a firmer financial footing and we're continuing to support them, including by increasing the amount they can charge in tuition fees.
'We are rebuilding the NHS for the benefit of patient and staff, and ensuring nursing remains an attractive career choice, including by unveiling a refreshed workforce plan to ensure we have the right staff in the right place so the NHS can be there for everyone.'
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Doctors try 'poo pills' to flush out dangerous superbugs
Doctors try 'poo pills' to flush out dangerous superbugs

Yahoo

time41 minutes ago

  • Yahoo

Doctors try 'poo pills' to flush out dangerous superbugs

UK doctors are attempting to clear dangerous superbug infections using "poo pills" containing freeze-dried faeces. The stool samples come from healthy donors and are packed with good bacteria. Early data suggests superbugs can be flushed out of the dark murky depths of the bowel and replaced with a mix of healthy gut bacteria. It is a new approach to tackling infections that resist antibiotics, which are thought to kill a million people each year. The focus is on the bowels which are "the biggest reservoir of antibiotic resistance in humans" says Dr Blair Merrick, who has been testing the pills at Guys and St Thomas' hospitals. Drug-resistant superbugs can escape their intestinal home and cause trouble elsewhere in the body – such as urinary tract or bloodstream infections. "So there's a lot of interest in 'can you get rid of them from the gut?'," says Dr Merrick. The idea of poo-pills isn't as far-fetched as it might seem. Faecal transplants – also known as a trans-poo-tion - are already approved for treating severe diarrhoea caused by Clostridium difficile bacteria. But scientists noticed hints that faecal transplants for C. difficile also seemed to get rid of superbugs. Microbiome podcast: Manipulating Our Hidden Half New research has focused on patients who had an infection caused by drug-resistant bacteria in the past six months. They were given pills made from faeces which people had donated to a stool bank. Each stool sample is tested to ensure it does not contain any harmful bugs, undigested food is removed and then it is freeze dried into a powder. This is stored inside a pill that can pass through the stomach unscathed and reach the intestines where it dissolves to release its poopy powdery payload. The trial has taken place on 41 patients at Guy's and St Thomas' hospitals in London to lay the groundwork for a large-scale study. It showed patients were up for taking a poo pill and the donated bacteria were still being detected in the bowels at least a month later. Dr Merrick says there are "really promising signals" that poo pills could help tackle the rising scourge of superbugs and that donor bacteria could be going to microbial war with the superbugs as they compete over food and space on the lining of the gut and either rid the body of them completely or "reduce them down to a level that doesn't cause problems". The study also suggests the array of gut bacteria becomes more varied after the therapy. This is a sign of good health and "may well be promoting colonisation resistance" so it is harder for new infectious bugs to get in. "It's very exciting. There's a real shift from 20 years ago where all bacteria and viruses were assumed to do you harm; to now where we realise they are completely necessary to our overall health," says Dr Merrick. Earlier this week scientists showed the good bacteria our bodies meet – in the hours after we are born – seem to halve the risk of young children being admitted to hospital with lung infections. First bacteria we ever meet can keep us out of hospital More than half your body is not human Our body's own human cells are outnumbered by the bacteria, fungi and others that live inside us - known as the microbiome. This has led to research implicating the microbiome in everything from Crohn's disease to cancer to mental health. If poo pills are proven to work against superbugs in larger studies then the researchers think they could be used for both treatment and prevention in people at risk. Medical procedures that suppress the immune system - including cancer therapies and organ transplants - can make the body more vulnerable. "A lot of these individuals come to a lot of harm from drug resistant organisms," Dr Merrick. The UK's drugs regulator – the Medicines and Healthcare Products Agency – said there were more than 450 microbiome medicines currently in development. "Some of them will success, so I do think we will seem them coming through quite soon," said Dr Chrysi Sergaki, the head of microbiome research at the MHRA. "We could potentially, in the future, replace antibiotics with microbiome [therapies] - that's the big picture, so there's a lot of potential."

7 myths and truths about inducing labour, from dancing to spicy food
7 myths and truths about inducing labour, from dancing to spicy food

Yahoo

timean hour ago

  • Yahoo

7 myths and truths about inducing labour, from dancing to spicy food

"Been pregnant for way too long." These lyrics, from the song Baby Mamma Dance, no doubt resonate with a lot of women in their third trimester – particularly if their baby is overdue or they're in the delivery room trying to induce labour. And although we can't be sure that that was the goal of those killer moves, Meghan Markle's video of her and Prince Harry twerking in the hospital to this song as they awaited the birth of their daughter Lilibet seems to speak to this. Of course, it's also quite possible that the pair were simply killing time and trying to lighten the mood before Meghan gave birth – or both. But dancing is, in fact, a good way to naturally encourage the baby along. Ruby Handley-Stone, midwife and professional advisor at the Royal College of Midwives, tells Yahoo UK: "Anything to help being upright and mobile is encouraged and will help with engagement of the baby's head and rotation. Equally, listening to music you love will help oxytocin and relaxation." Here, we take a look at seven myths and truths about inducing labour. A herbal tea high in vitamins, minerals and tannins, raspberry leaf tea is thought by some to help tone the muscles of the womb for when you go into labour. It can also help combat nausea. That said, health professionals don't suggest drinking the tea to induce labour, and it's unsure how safe it is in pregnancy. According to Tommy's pregnancy and baby charity, if you are going to consume it, it should be in the weeks leading up to your due date, starting with one cup a day and steadily increasing to three cups, spread throughout the day. They also advise speaking to your midwife or doctor before trying any herbal remedies, like raspberry leaf tea, as it may not be safe for everyone. The theory is that by eating spicy foods, you can stimulate your gut and in turn prompt contractions. But it can also bring on heartburn, so if you are prone to indigestion and acid reflux, it's probably best to avoid. Although the NCT says there's no evidence to suggest that spicy food can induce labour, there also isn't any harm in trying it. Whether you go for a stroll or rock on a birthing ball, gentle exercise has been linked to inducing labour. Being upright and moving about may help your baby settle into your pelvis. It is a common misconception that having sex while pregnant may hurt the baby. But, thanks to the amniotic sac, your child is protected from infection – plus a penis or sex toy cannot penetrate beyond the cervix. While having sex during pregnancy won't harm the baby and is perfectly safe for most people – unless a health professional advises against it – there isn't any evidence to suggest it can bring on labour. What may happen as a result of an orgasm in the later stages, though, is that you experience Braxton Hicks contractions (also referred to as "practice contractions"). This is perfectly normal, albeit uncomfortable, and you might want to lie down and relax until they pass. You can read the NCT's guide to sex during pregnancy for more information. Rich in fibre and antioxidants, dates are nutritious at the best of times, but there is also a theory they can help induce labour. A small study by the Jordan University of Science and Technology in 2008, for example, examined 69 women who ate six date fruits each day in the four weeks prior to their due date and compared them to 45 women who consumed none. The researchers found that spontaneous labour occurred in 96% of those who consumed dates, compared with 79% women in the non-date fruit consumers. Research suggests that breast stimulation increases the number of women in labour within 72 hours, as it encourages the body's production of oxytocin – the same hormone that prompts contractions in labour. Before trying any methods, though, it's always best to speak to your health team first. Previously, ingesting castor oil was recommended as a way to bring on labour, and there is some evidence to suggest it can work. That said, it is not advised you take castor oil while pregnant as it can lead to nausea, high blood pressure and digestive distress. Handley-Stone stresses: "There's very little safe evidence for midwives to recommend many of the 'old wives' tales', and techniques such as hot baths, castor oil and sexual intercourse aren't advised in official guidelines. "Similarly, there is little research that herbal teas influence the start of labour and some may actually be harmful – this is the same for essential oils. There is also some evidence to suggest that acupuncture may help the cervix to soften, but this is also limited." She continues: "Generally, although some methods may offer relaxation (which is the best thing to start labour!), it's always worth consulting your midwife before trying any complementary therapies to ensure they are safe and appropriate for you. Your baby will come when they're ready!" Read more about pregnancy and giving birth What Jamie Laing has said about parenthood as he announces pregnancy with Sophie Habboo (Yahoo Life UK, 4-min read) How the most popular baby girl names in the UK compare with the US (Yahoo Life UK, 8-min read) Why it's not OK to speculate if someone's pregnant (Yahoo Life UK, 4-min read)

Pegcetacoplan Maintains Kidney Benefits at 52 Weeks
Pegcetacoplan Maintains Kidney Benefits at 52 Weeks

Medscape

timean hour ago

  • Medscape

Pegcetacoplan Maintains Kidney Benefits at 52 Weeks

Pegcetacoplan, a targeted C3/C3b inhibitor, shows sustained, robust effects on key markers of kidney disease in patients with C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN), according to 52-week results from the VALIANT trial. The 26-week results, which were presented last October at Kidney Week 2024, showed a highly significant difference in change in proteinuria from baseline, as measured by the urine protein-to-creatinine ratio (uPCR); the reduction was 67.2% with pegcetacoplan vs 2.9% with placebo ( P < .0001). The current findings showed that not only were these benefits sustained in patients who remained on pegcetacoplan, patients who switched from placebo to pegcetacoplan also experienced reductions of similar magnitude, said Fadi Fakhouri, MD, of Lausanne University Hospital and the University of Lausanne, Switzerland. Fakhouri presented the 1-year results at the 62nd European Renal Association (ERA) Congress 2025. VALIANT Open-Label Period The phase 3 VALIANT trial involved 124 patients with native or post-transplant recurrent C3 glomerulopathy or primary IC-MPGN who were randomly assigned to treatment two times a week with either subcutaneous pegcetacoplan 1080 mg, or weight-based doses for adolescents weighing ≤50 kg (n = 63); or to placebo (n = 61). In the subsequent 26-week open-label period, the placebo group crossed over and all patients received pegcetacoplan. Overall, 59 (93.7%) people in the pegcetacoplan group and 55 (90.2%) in the placebo group completed the study treatment and 52-week assessment. At week 52, patients in the original pegcetacoplan group maintained the significant proteinuria reduction that was observed at week 26, with a mean urine protein-to-creatinine ratio (UPCR) change at week 26 of –67.2% and at week 52 of –68.3%. Patients in the placebo group, who experienced a +3.2% change in uPCR at week 26, experienced a reduction of –51.3% at week 52 after being switched to pegcetacoplan. In addition, eGFR levels in the pegcetacoplan group dropped slightly from -1.2 mL/min/1.73 m2 at week 26 to -3.7 mL/min/1.73 m2 at week 52; in the placebo-to-pegcetacoplan group, the corresponding changes were -7.9 mL/min/1.73 m2 at week 26 and -4.7 mL/min/1.73 m2 at week 52. In terms of safety, pegcetacoplan remained well-tolerated in the second 26 weeks, and treatment-emergent adverse events (TEAEs) were similar between the two arms during the open-label period (pegcetacoplan-to-pegcetacoplan, 77%; placebo-to-pegcetacoplan, 73.7%). Overall, infusion-related TEAEs decreased from the randomized to open-label period in the pegcetacoplan-to-pegcetacoplan group (33.3% vs 9.8%, respectively), suggesting an improvement in tolerability over time. Adherence was high, at 97.6% of patients having an adherence of ≥90% to ≤100%, overall. Infections included two cases of pneumococcal pneumonia (including one that was serious) occurring during the open-label period, and there was one case each of streptococcal pharyngitis and urinary tract infection caused by Escherichia . No patient deaths or allograft losses were reported. 'The open-label period results confirm pegcetacoplan's significant effect on kidney function,' Fakhouri said. 'Patients in the placebo arm experienced a decline in eGFR during the randomized controlled period, but a stabilization after switching to pegcetacoplan, comparable to randomized controlled period results in the pegcetacoplan group,' he added. Patients With Baseline Nephrotic Range Proteinuria The results of subanalyses looking at several other trial outcomes were also presented at the meeting. These included an analysis of patients with nephrotic range proteinuria at baseline, who are at a notably high risk of rapid disease progression to kidney failure. At baseline, 24 patients in the pegcetacoplan arm (38.1%) and 16 in the placebo arm (26.2%) had nephrotic range proteinuria, defined as a uPCR ratio ≥3 g/g. At the end of the initial 26-week period, among patients with nephrotic range proteinuria, those treated with pegcetacoplan had a relative reduction of proteinuria of 72.1% compared with placebo ( P < .0001). Patients Treated With Immunosuppressive Therapies A second subanalysis evaluated outcomes among 48 (76%) participants in the pegcetacoplan group and 42 (69%) in the placebo group who were receiving concomitant immunosuppressive therapy at baseline. Patients were permitted to continue the immunosuppressants provided that the doses had remained stable during the preceding 12-week period and throughout the trial. The outcomes between the two groups were similar: Immunosuppressant-treated patients who received pegcetacoplan had a relative reduction of 70% in proteinuria vs placebo ( P < .0001), and among patients who did not receive immunosuppressants, the relative reduction was 64.5% compared to placebo ( P = .0005). At week 26, 62.5% (30/48) of immunosuppressant‐treated patients receiving pegcetacoplan achieved a ≥50% reduction in proteinuria from baseline vs 4.8% (2/42) on placebo ( P < .0001). Among those not on immunosuppressants, 53.3% (8/15) of the pegcetacoplan group met the same endpoint compared with 5.3% (1/19) in the placebo arm ( P = .0087). 'Reassuringly, proteinuria was reduced in both groups, and the immunosuppressed group had a highly statistically significant reduction,' said David Kavanagh, MD, of the National Renal Complement Therapeutics Centre, Newcastle University, Newcastle upon Tyne, United Kingdom, who presented this subanalysis. Other outcomes, including stabilization of eGFR, were also similar to the overall reductions, including those patients not on immunosuppressants. Importantly, rates of TEAEs were also comparable between the immunosuppressed and non-immunosuppressed patients. 'If you can reduce your proteinuria by at least 50%, you're going to have an outcome that can reduce the risk of kidney failure,' Kavanagh concluded. The studies were sponsored by Apellis. Fakhouri reported relationships with Apellis, Sobi, Novartis, Roche, Alexion Pharmaceuticals, and AstraZeneca. Kavanagh reported relationships with Idorsia, Novartis, Chemocentryx, Alexion Pharmaceuticals, Samsung, Sobi, Gyroscope Therapeutics, Purespring, and Apellis.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store